Parnax Lab Ltd
506128NSE
₹0.00▲ +0.00 (+0.00%)
Mkt cap₹155 Cr
P/E13.44
Volume—
Day range—
52W range108.03 – 144.95
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
Parnax Lab Ltd (506128): company summary
Parnax Lab Ltd (506128) is a micro-cap Healthcare company valued at ₹155 crore operating in Pharmaceuticals on the NSE and BSE.
Parnax Lab Ltd (506128) is a micro-cap Healthcare company valued at ₹155 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 13.9% a year over three years; profit grew 10.9% a year, behind revenue — margins are under pressure. Return on equity is 14.4%.
- Valuation multiples
- The stock trades at 13.4 times earnings, a discount to the Healthcare median of 32.0, 1.62 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
52W₹108.03
₹144.95
Key numbers
Price-based figures are live; statement figures are from FY26, consolidated where filed.
Valuation
- Market cap
- ₹155 Cr
- P/E
- 13.4×
- P/B
- 1.6×
- P/S
- —
- EV/EBITDA
- —
- Earnings yield
- 7.4%
- Dividend yield
- 0.00%
- Fair value
Profitability
- ROE
- 14.4%
- ROCE
- 14.0%
- ROIC
- —
- ROA
- —
- Gross margin
- —
- Operating margin
- 14.0%
- Net margin
- 6.4%
- EPS (TTM/FY)
- ₹10.03
Growth
- Sales · last qtr YoY
- —
- Profit · last qtr YoY
- —
- Sales · 1Y
- —
- Profit · 1Y
- —
- Sales CAGR · 3Y / 5Y
- +14% / +23%
- Profit CAGR · 3Y / 5Y
- +11% / —
- EPS CAGR · 5Y
- —
- Sales CAGR · 10Y
- +13%
Balance sheet
- Debt / equity
- 0.87
- Net debt / EBITDA
- —
- Interest cover
- —
- Current ratio
- —
- Total debt
- ₹83 Cr
- Cash
- —
- Book value / share
- ₹82.8
- Free cash flow
- −₹9 Cr
Quality & trading
- Piotroski F-score
- —
- Altman Z
- —
- Cash conversion cycle
- 65 days
- Dividend payout
- 0%
- Delivery %
- —
- Volume vs 30D avg
- —
- Avg traded value
- —
- Face value
- ₹10.00
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Parnax Lab Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Parnax Lab Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedDr. Reddy's Laboratories LimitedCipla LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Parnax Lab Ltd with peers
Related tools & concepts
Value Parnax Lab Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing